Spotlight on P2X7 Receptor PET Imaging: A Bright Target or a Failing Star?

Int J Mol Sci

European Institute for Molecular Imaging, University of Münster, Waldeyerstr. 15, 48149 Münster, Germany.

Published: January 2023

The homotrimeric P2X7 receptor (P2X7R) is expressed by virtually all cells of the innate and adaptive immune system and plays a crucial role in various pathophysiological processes such as autoimmune and neurodegenerative diseases, inflammation, neuropathic pain and cancer. Consequently, the P2X7R is considered a promising target for therapy and diagnosis. As the development of tracers comes hand-in-hand with the development of potent and selective receptor ligands, there is a rising number of PET tracers available in preclinical and clinical studies. This review analyzes the development of P2X7R positron emission tomography (PET) tracers and their potential in various PET imaging applications.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861945PMC
http://dx.doi.org/10.3390/ijms24021374DOI Listing

Publication Analysis

Top Keywords

p2x7 receptor
8
pet imaging
8
pet tracers
8
spotlight p2x7
4
pet
4
receptor pet
4
imaging bright
4
bright target
4
target failing
4
failing star?
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!